Specifica, a IQVIA Laboratories company, improves the affinity and developability of client-supplied antibodies. Specifica guarantees at least 10-fold increase in affinity while simultaneously improving developability. Our two-stage procedure preserves epitope recognition and eliminates CDRs containing sequence liabilities. Our maturation process improves maturation affinity 10- to 200-fold.
Download Document
Download Document
